Medtronic Earnings Preview: U.S. ICD Sales, Emerging Markets In Focus

When Medtronic comes out with its Q2 FY 2015 earnings, we expect sales growth to meet the company?s guidance of 3-5%. Most of the company?s major businesses are likely to sustain their growth momentum as new products have found strong acceptance. We also expect gross margins to remain below 75% as Medtronic?s cost saving efforts are offset by growing pricing pressures and product quality issues in some divisions.